Evidence map›Paper›PMID 39411129›Full record

ArticleFrontiers in oncology2024

Case report: Germline

Yongfeng Bi, Dong Wan, Si Chen, Huafei Chen, Lingchuan Guo, Xiaoshun He, Rong Rong, Jinyuan Xiao, Wei Gao, Sheng Xiao

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Cancer biology & therapy · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yongfeng Bi *Department of Neurosurgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
Dong Wan *Advanced Molecular Pathology Institute of Soochow University and SANO, Suzhou, China.
Si ChenAdvanced Molecular Pathology Institute of Soochow University and SANO, Suzhou, China.
Huafei ChenAdvanced Molecular Pathology Institute of Soochow University and SANO, Suzhou, China.
Lingchuan GuoAdvanced Molecular Pathology Institute of Soochow University and SANO, Suzhou, China.
Xiaoshun HeDepartment of Pathology, The First Affiliated Hospital of Soochow University, Suzhou, China.
Rong RongDepartment of Biological Sciences, Xi An Jiaotong-Liverpool University, Suzhou, China.
Jinyuan XiaoThe College of Informatics, Huazhong Agricultural University, Wuhan, China.
Wei GaoDepartment of Neurosurgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
Sheng XiaoDepartment of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Giant cell glioblastoma often exhibits genome instability and is frequently associated with mutations in genes involved in DNA repair pathways including

Indexed as

CHEK2germlineglioblastomahaploidyMET

Identifiers

PMID39411129
PMCPMC11474180

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.